These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6192674

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Isoprinosine in subacute sclerosing panencephalitis.
    Huttenlocher PR, Mattson RH.
    Neurology; 1979 Jun; 29(6):763-71. PubMed ID: 88024
    [Abstract] [Full Text] [Related]

  • 7. Long-term study of isoprinosine in a case of subacute sclerosing panencephalitis.
    De Reuck JL, Boon PA, Krahel NL.
    Eur Neurol; 1985 Jun; 24(5):294-7. PubMed ID: 2414109
    [Abstract] [Full Text] [Related]

  • 8. Use of isoprinosine in subacute sclerosing panencephalitis.
    McGrath E, Rosenbloom L.
    Arch Dis Child; 1980 Oct; 55(10):829-30. PubMed ID: 6159826
    [No Abstract] [Full Text] [Related]

  • 9. SSPE treated with isoprinosine: immunopathological observations.
    Streletz LJ, Sethi BS, Graziani LJ, Duckett SW.
    Ann Neurol; 1985 Jan; 17(1):105-6. PubMed ID: 2580477
    [No Abstract] [Full Text] [Related]

  • 10. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
    Haddad FS, Risk WS.
    Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
    DuRant RH, Dyken PR, Swift AV.
    J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis.
    Tekgül H, Tutuncuoglu S, Kutukçuler N, Dizdarer G, Huseyinov A.
    J Child Neurol; 1999 Jul; 14(7):418-21. PubMed ID: 10573462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.